Status:
NOT_YET_RECRUITING
Evaluation of the PROSTia Test in Patients Undergoing Prostate Biopsy
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Prostate Cancer (Adenocarcinoma)
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The investigators are interested here in the contribution of a new prostate cancer screening method and, more specifically, in the new and somewhat futuristic approach of artificial intelligence in th...
Detailed Description
.1. Outline of the study The lack of accuracy of the PSA test for prostate cancer screening leads to negative biopsies. The aim of this study is to determine whether the PROSTia test, a personalised m...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients followed up at the Nancy CHRU in the Urology Department and eligible for a prostate biopsy in search of prostate cancer, taking into account an increase in PSA, PSA density, lesion on MRI.
- Person who has received full information about the organisation of the research and has not objected to their participation and the use of their data.
- Adult male over 18 years of age - Patient affiliated to or benefiting from a social security scheme - Patient who understands French and is able to fill in a self-administered questionnaire or who has the possibility to be assisted in filling it in.
- Exclusion criteria:
- Patients who have already had a prostate biopsy
- Patients under court protection, guardianship or trusteeship
- Patients deprived of liberty by judicial or administrative decision
Exclusion
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06931496
Start Date
April 15 2025
End Date
November 1 2025
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Vandœuvre-lès-Nancy, France, France, 54500